Skip to Main Content

Author Details

Sherrie L Perkins
University of Utah
1982
210
49
PMIDPaper TitleJournal TitlePublished Year
37638547Significant Variability in the Identification and Reporting of Band Neutrophils by Participants Enrolled in the College of American Pathologists Proficiency Testing Program: Time for a Change.Arch Pathol Lab Med2024
37638547Significant Variability in the Identification and Reporting of Band Neutrophils by Participants Enrolled in the College of American Pathologists Proficiency Testing Program: Time for a Change.Arch Pathol Lab Med2024
34297047Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma.Blood Adv2021
34297047Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma.Blood Adv2021
33941850A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma.Leukemia2021
33941850A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma.Leukemia2021
32552472Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434.J Clin Oncol2020
32552472Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434.J Clin Oncol2020
31012208IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials.Pediatr Blood Cancer2019
30117142Excellent outcomes in children and adolescents with CNS<sup>+</sup> Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1.Br J Haematol2019
31012208IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials.Pediatr Blood Cancer2019
31245191Prognostic Significance of the Dynamic Change of Programmed Death-ligand 1 Expression in Patients with Multiple Myeloma.Cureus2019
31305383The Influence of Aspiration Volume on the Number of Osteoblastic Progenitors Obtained From Bone Marrow in Children.J Pediatr Orthop2019
30117142Excellent outcomes in children and adolescents with CNS<sup>+</sup> Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1.Br J Haematol2019
31245191Prognostic Significance of the Dynamic Change of Programmed Death-ligand 1 Expression in Patients with Multiple Myeloma.Cureus2019
31305383The Influence of Aspiration Volume on the Number of Osteoblastic Progenitors Obtained From Bone Marrow in Children.J Pediatr Orthop2019
29336635Lymphomatoid Granulomatosis in a 14-Year-Old Boy with Trisomy 21 and History of B-Lymphoblastic Leukemia/Lymphoma.Fetal Pediatr Pathol2018
30546948Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,<i>in-vitro</i> proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model.Oncoimmunology2018
29984828Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group.Br J Haematol2018
29336635Lymphomatoid Granulomatosis in a 14-Year-Old Boy with Trisomy 21 and History of B-Lymphoblastic Leukemia/Lymphoma.Fetal Pediatr Pathol2018
29984828Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group.Br J Haematol2018
30546948Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,<i>in-vitro</i> proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model.Oncoimmunology2018
27957801Genomic characterization of pediatric B-lymphoblastic lymphoma and B-lymphoblastic leukemia using formalin-fixed tissues.Pediatr Blood Cancer2017
28427156The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BL.Oncotarget2017
28752840Genetic evaluation of juvenile xanthogranuloma: genomic abnormalities are uncommon in solitary lesions, advanced cases may show more complexity.Mod Pathol2017
28621320Genomic analysis of follicular dendritic cell sarcoma by molecular inversion probe array reveals tumor suppressor-driven biology.Mod Pathol2017
28474336Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report.Br J Haematol2017
27957801Genomic characterization of pediatric B-lymphoblastic lymphoma and B-lymphoblastic leukemia using formalin-fixed tissues.Pediatr Blood Cancer2017
28427156The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BL.Oncotarget2017
28474336Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report.Br J Haematol2017
28752840Genetic evaluation of juvenile xanthogranuloma: genomic abnormalities are uncommon in solitary lesions, advanced cases may show more complexity.Mod Pathol2017
28621320Genomic analysis of follicular dendritic cell sarcoma by molecular inversion probe array reveals tumor suppressor-driven biology.Mod Pathol2017
26728447Rare Pediatric Non-Hodgkin Lymphomas: A Report From Children's Oncology Group Study ANHL 04B1.Pediatr Blood Cancer2016
27292444Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias.Br J Haematol2016
26728447Rare Pediatric Non-Hodgkin Lymphomas: A Report From Children's Oncology Group Study ANHL 04B1.Pediatr Blood Cancer2016
27124945Prognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated With R-CHOP Chemotherapy.Am J Clin Pathol2016
26991119Current status and future directions of T-lymphoblastic lymphoma in children and adolescents.Br J Haematol2016
26905483Bone Marrow Synoptic Reporting for Hematologic Neoplasms: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center.Arch Pathol Lab Med2016
26419289Increased frequency of co-existing JAK2 exon-12 or MPL exon-10 mutations in patients with low JAK2(V617F) allelic burden.Leuk Lymphoma2016
26686246Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation.Leukemia2016
26419289Increased frequency of co-existing JAK2 exon-12 or MPL exon-10 mutations in patients with low JAK2(V617F) allelic burden.Leuk Lymphoma2016
27124945Prognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated With R-CHOP Chemotherapy.Am J Clin Pathol2016
27292444Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias.Br J Haematol2016
26991119Current status and future directions of T-lymphoblastic lymphoma in children and adolescents.Br J Haematol2016
26686246Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation.Leukemia2016
26905483Bone Marrow Synoptic Reporting for Hematologic Neoplasms: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center.Arch Pathol Lab Med2016
24913506Neoplastic plasma cell aberrant antigen expression patterns and their association with genetic abnormalities.Leuk Lymphoma2015
25780014Clinicopathologic evaluation of MYC expression in primary mediastinal (thymic) large B-cell lymphoma.Am J Clin Pathol2015
25858645Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children's Oncology Group Pilot Study Report.Br J Haematol2015
25851546Uncommon non-Hodgkin lymphomas of childhood: pathological diagnosis, clinical features and treatment approaches.Br J Haematol2015
  • 1 - 50 of 420

Recommended Authors

Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 1
Xiaoqiong Wang
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Alexa J Siddon
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 1
David Wu
University of Washington
Career Start Year 2010
Number of shared co-authors 5
Jennifer Dunlap
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 3
Robin D LeGallo
University of Virginia Department of Pathology
Career Start Year 2001
Number of shared co-authors 15
Guang Fan
Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 1
Gyeongsin Park
Seoul St. Mary's Hospital, The Catholic University of Korea
Career Start Year 1999
Number of shared co-authors 0
Sze Fai Yip
Tuen Mun Hospital
Career Start Year 1999
Number of shared co-authors 0
Scott C Borinstein
Vanderbilt University Medical Center
Career Start Year 1998
Number of shared co-authors 1
Andrew M Evens
Rutgers Robert Wood Johnson Medical School
Career Start Year 1998
Number of shared co-authors 2
Eric Tse
School of Clinical Medicine, University of Hong Kong
Career Start Year 1997
Number of shared co-authors 1
Francisco Vega
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 3
Jean Soulier
University of Paris
Career Start Year 1993
Number of shared co-authors 3
Arndt Borkhardt
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 1
Christopher D Gocke
Johns Hopkins University School of Medicine
Career Start Year 1992
Number of shared co-authors 3
Michael Weintraub
Hadassah Hebrew University Hospital
Career Start Year 1992
Number of shared co-authors 0
Kikkeri N Naresh
Fred Hutchinson Cancer Research Center
Career Start Year 1989
Number of shared co-authors 3
Shifra Ash
Ruth Rappaport Children's Hospital
Career Start Year 1988
Number of shared co-authors 1
Kim E Nichols
St. Jude Children's Research Hospital
Career Start Year 1986
Number of shared co-authors 6
David M Dorfman
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1982
Number of shared co-authors 2
Maryalice Stetler-Stevenson
National Cancer Institute, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 6
Mark Raffeld
Center for Cancer Research, National Cancer Institute
Career Start Year 1981
Number of shared co-authors 7
Stefan Burdach
Technische Universitat Munchen
Career Start Year 1981
Number of shared co-authors 2
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 1
Stefania Pittaluga
National Cancer Institute, National Institutes of Health
Career Start Year 1979
Number of shared co-authors 8
Sanford A Stass
University of Maryland School of Medicine
Career Start Year 1977
Number of shared co-authors 2
Dennis B Cornfield
Lehigh Valley Hospital
Career Start Year 1977
Number of shared co-authors 2
Thomas J Kipps
University of California San Diego
Career Start Year 1977
Number of shared co-authors 2
Robin Fo??
Sapienza University.
Career Start Year 1968
Number of shared co-authors 2

Collaborators

Jonathan L Finlay
Nationwide Children's Hospital and The Ohio State University
Co-authored papers 8
Melissa H Cessna
Intermountain Medical Center
Co-authored papers 5
Stefan Schreiber
Co-authored papers 4
Jean Michon
Institut Curie
Co-authored papers 4
Sarah T South
Co-authored papers 3
Elaine S Jaffe
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Mignon L Loh
University of Washington
Co-authored papers 2
Jason L Hornick
Brigham and Women's Hospital and Harvard Medical School
Co-authored papers 2
Birgit Burkhardt
Co-authored papers 2
Stephen P Hunger
Children's Hospital of Philadelphia
Co-authored papers 2
Meenakshi Devidas
St Jude Children's Research Hospital
Co-authored papers 2
Bayardo Perez-Ordonez
University Health Network
Co-authored papers 2
Koichi Nishijo
Institute for Frontier Medical Sciences, Kyoto University
Co-authored papers 1
Matthew N Svalina
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Pei Lin
Co-authored papers 1
Xinjie Xu
Mayo Clinic
Co-authored papers 1
Olivia O Recht
Lillehei Heart Institute, University of Minnesota
Co-authored papers 1
Daniel C Link
Washington University School of Medicine
Co-authored papers 1
Daniel W Fults
Co-authored papers 1
Bradley L Demarest
Co-authored papers 1
Joel E Michalek
University of Texas Health Science Center
Co-authored papers 1
Leonard S Sender
Co-authored papers 1
Elias Campo
Institute for Biomedical Research August Pi I Sunyer
Co-authored papers 1
Eri Taniguchi
Kyoto University
Co-authored papers 1
M??nica Suelves
Germans Trias i Pujol Research Institute
Co-authored papers 1
Michael Laposata
University of Texas Medical Branch
Co-authored papers 1
Heather Gilbert
Co-authored papers 1
Paul E Steele
Cincinnati Children's Hospital
Co-authored papers 1
Lee Ann Zarzabal
University of Texas Health Science Center
Co-authored papers 1
Jeremy C Wallentine
Intermountain Medical Center
Co-authored papers 1
Release 1.2